If a researcher takes a swab of your nose and finds a new species of bacteria, the discovery of which leads to the development of a new drug, do you deserve a cut of those profits, asks Carl Zimmer in The New York Times. More and more, bioethicists are asking questions about people's relationships with their microbiomes, Zimmer says.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.